Aziz Ullah

2PUBLICATIONS
2CO-AUTHORS
Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 27, 2026
Resveratrol as a Dual MAPK/STAT3 Inhibitor in Glioblastoma: Mutation-Dependent Therapeutic Efficacy.

|Mar 14, 2026
Resveratrol and AG490 Overcome Glioblastoma Cells' Resistance to Monotherapy by Inhibiting JAK2/STAT3 Signalling Pathway.

Aziz Ullah, Chuanchun Han

Pageof 1

Frequent Collaborators

1 joint publications

Mohammad Abdullah Aljasir

1 joint publications

Sajjad Ahmad